Dr Frank Carr, Director of Biologics Research will be presenting a paper entitled "Overcoming Adverse Immunogenicity Against Therapeutic Antibodies".  This paper will discuss the process of engineering antibodies without T cell epitopes to minimize the risk of immunogenicity in the clinic and show data from several projects.